中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
机构
采集方式
内容类型
发表日期
学科主题
筛选

浏览/检索结果: 共33条,第1-10条 帮助

条数/页: 排序方式:
Integrative study of lung cancer adeno-to-squamous transition in EGFR TKI resistance identifies RAPGEF3 as a therapeutic target 期刊论文  OAI收割
NATIONAL SCIENCE REVIEW, 2024, 卷号: 11, 期号: 12, 页码: 20
作者:  
Wang, Hua;  Tang, Shijie;  Wu, Qibiao;  He, Yayi;  Zhu, Weikang
  |  收藏  |  浏览/下载:14/0  |  提交时间:2025/02/28
Design and Synthesis of Dual Galectin-3 and EGFR Inhibitors Against Liver Fibrosis 期刊论文  OAI收割
CHEMISTRY-AN ASIAN JOURNAL, 2024, 页码: 14
作者:  
Liu, Shuanglin;  He, Fei;  Jin, Can;  Li, Qing;  Zhao, Guilong
  |  收藏  |  浏览/下载:7/0  |  提交时间:2024/12/25
Discovery of HCD3514 as a potent EGFR inhibitor against C797S mutation in vitro and in vivo 期刊论文  OAI收割
JOURNAL OF CANCER, 2023, 卷号: 14, 期号: 1, 页码: 152-162
作者:  
Lai, Mengzhen;  Zhang, Tao;  Chen, Hao;  Song, Peiran;  Tong, Linjiang
  |  收藏  |  浏览/下载:121/0  |  提交时间:2023/04/10
Efficient Synthesis and Biological Evaluation of 6-Trifluoroethoxy Functionalized Pteridine Derivatives as EGFR Inhibitors 期刊论文  OAI收割
MEDICINAL CHEMISTRY, 2022, 卷号: 18, 期号: 3, 页码: 353-363
作者:  
Lin, Jin;  Zhang, Zemin;  Lin, Xiongqiang;  Chen, Zhendong;  Luc, Tian
  |  收藏  |  浏览/下载:37/0  |  提交时间:2022/06/15
Third-generation EGFR inhibitor HS-10296 in combination with famitinib, a multi-targeted tyrosine kinase inhibitor, exerts synergistic antitumor effects through enhanced inhibition of downstream signaling in EGFR-mutant non-small cell lung cancer cells 期刊论文  OAI收割
THORACIC CANCER, 2021, 页码: 9
作者:  
Zhang, Mi;  Quan, Haitian;  Fu, Li;  Li, Yun;  Fu, Haoyu
  |  收藏  |  浏览/下载:65/0  |  提交时间:2021/05/24
Musarin, a novel protein with tyrosine kinase inhibitory activity from Trametes versicolor, accepted inhibits colorectal cancer stem cell growth 期刊论文  OAI收割
BIOMEDICINE & PHARMACOTHERAPY, 2021, 卷号: 144, 页码: 112339
作者:  
He,YingYing;  Liu,Shubai;  Newburg,David S.
  |  收藏  |  浏览/下载:49/0  |  提交时间:2022/04/02
Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance 期刊论文  OAI收割
MOLECULAR CANCER, 2020, 卷号: 19, 期号: 1, 页码: 15
作者:  
Zhang, Tao;  Qu, Rong;  Chan, Shingpan;  Lai, Mengzhen;  Tong, Linjiang
  |  收藏  |  浏览/下载:91/0  |  提交时间:2020/07/01
Discovery of Potent and Noncovalent Reversible EGFR Kinase Inhibitors of EGFR(L858R/T790M/C797S) 期刊论文  OAI收割
ACS MEDICINAL CHEMISTRY LETTERS, 2019, 卷号: 10, 期号: 6, 页码: 869-873
作者:  
Li, Qiannan;  Zhang, Tao;  Li, Shiliang;  Tong, Linjiang;  Li, Junyu
  |  收藏  |  浏览/下载:64/0  |  提交时间:2020/07/01
EGFR  mutant  inhibitor  C797S  
YL143, a novel mutant selective irreversible EGFR inhibitor, overcomes EGFR(L858R, T790M)-mutant resistance in vitro and in vivo 期刊论文  OAI收割
CANCER MEDICINE, 2018, 卷号: 7, 期号: 4, 页码: 1430-1439
作者:  
Zhang, Zhang;  Zou, Jian;  Yu, Lei;  Luo, Jinfeng;  Li, Yan
  |  收藏  |  浏览/下载:79/0  |  提交时间:2019/01/08
Identifying egfr-expressed cells and detecting egfr multi-mutations at single-cell level by microfluidic chip 期刊论文  iSwitch采集
Nano-micro letters, 2018, 卷号: 10, 期号: 1, 页码: 10
作者:  
Li, Ren;  Zhou, Mingxing;  Li, Jine;  Wang, Zihua;  Zhang, Weikai
收藏  |  浏览/下载:101/0  |  提交时间:2019/04/23